Drugs / HAE1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00406965 | Dec 2006 → Sep 2007 | allergic asthma | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAE1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00406965 ↗ |
| Known as | PRO98498 | “HAE1 (PRO98498)” NCT00406965 ↗ |
| Route | Subcutaneous | “subcutaneously administered HAE1” NCT00406965 ↗ |